Note 4 - Business Combination - Purchase Considerations (Details) - USD ($) $ in Thousands |
Apr. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|---|
| Goodwill | $ 5,175 | $ 0 | |
| Evoke Neuroscience, Inc. [Member] | |||
| Cash | $ 3,000 | ||
| Common stock | 2,743 | ||
| Earn-Out Shares | 478 | ||
| Total Purchase Consideration | 6,221 | ||
| Working capital | 139 | ||
| Security deposit | 3 | ||
| Deferred revenue, non-current portion | 56 | ||
| Fair Value of Identified Net Assets | 1,046 | ||
| Goodwill | 5,175 | ||
| Evoke Neuroscience, Inc. [Member] | Developed Technology Rights [Member] | |||
| Identified intangible asset | 700 | ||
| Evoke Neuroscience, Inc. [Member] | Trade Names [Member] | |||
| Identified intangible asset | 150 | ||
| Evoke Neuroscience, Inc. [Member] | Noncompete Agreements [Member] | |||
| Identified intangible asset | $ 110 |
| X | ||||||||||
- Definition Amount of asset acquired in business combination and recognized at acquisition date, classified as a security deposit and current. No definition available.
|
| X | ||||||||||
- Definition Amount of asset acquired in business combination and recognized at acquisition date, classified as working capital. No definition available.
|
| X | ||||||||||
- Definition Amount of deferred revenue assumed in business combination and recognized at acquisition date, classified as noncurrent. No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of identifiable finite-lived intangible asset acquired in business combination and recognized at acquisition date. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|